Goldman Sachs Group Inc Artivion, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 184,429 shares of AORT stock, worth $5.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184,429
Previous 184,429 -0.0%
Holding current value
$5.46 Million
Previous $4.53 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$23.19 - $31.7 $715,968 - $978,705
-30,874 Reduced 14.34%
184,429 $4.53 Million
Q4 2024

Feb 11, 2025
BUY
$25.41 - $30.11 $752,288 - $891,436
29,606 Added 15.94%
215,303 $6.2 Million
Q3 2024

Nov 14, 2024
BUY
$24.33 - $28.46 $448,645 - $524,802
18,440 Added 11.02%
185,697 $4.94 Million
Q2 2024

Aug 13, 2024
SELL
$19.62 - $25.65 $7,023 - $9,182
-358 Reduced 0.21%
167,257 $4.29 Million
Q1 2024

May 15, 2024
SELL
$16.7 - $21.63 $560,268 - $725,664
-33,549 Reduced 16.68%
167,615 $3.55 Million
Q4 2023

Feb 13, 2024
SELL
$12.33 - $18.83 $144,137 - $220,122
-11,690 Reduced 5.49%
201,164 $3.6 Million
Q3 2023

May 14, 2024
BUY
$14.82 - $17.52 $173,245 - $204,808
11,690 Added 5.81%
212,854 $3.23 Million
Q3 2023

Nov 14, 2023
SELL
$14.82 - $17.52 $461,894 - $546,045
-31,167 Reduced 12.77%
212,854 $3.23 Million
Q2 2023

May 14, 2024
BUY
$12.78 - $17.23 $119,659 - $161,324
9,363 Added 3.99%
244,021 $4.19 Million
Q2 2023

Aug 14, 2023
BUY
$12.78 - $17.23 $119,659 - $161,324
9,363 Added 3.99%
244,021 $4.19 Million
Q1 2023

May 14, 2024
BUY
$11.74 - $14.12 $647,648 - $778,943
55,166 Added 30.73%
234,658 $3.07 Million
Q1 2023

May 11, 2023
BUY
$11.74 - $14.12 $647,648 - $778,943
55,166 Added 30.73%
234,658 $3.07 Million
Q4 2022

May 14, 2024
SELL
$10.01 - $13.9 $1.04 Million - $1.44 Million
-103,534 Reduced 36.58%
179,492 $2.18 Million
Q4 2022

Feb 13, 2023
SELL
$10.01 - $13.9 $1.04 Million - $1.44 Million
-103,534 Reduced 36.58%
179,492 $2.18 Million
Q3 2022

May 14, 2024
SELL
$13.31 - $23.25 $217,245 - $379,486
-16,322 Reduced 5.45%
283,026 $3.92 Million
Q3 2022

Nov 10, 2022
SELL
$13.31 - $23.25 $217,245 - $379,486
-16,322 Reduced 5.45%
283,026 $0
Q2 2022

May 14, 2024
BUY
$15.73 - $22.91 $1.54 Million - $2.25 Million
98,184 Added 48.81%
299,348 $5.65 Million
Q2 2022

Aug 15, 2022
BUY
$15.73 - $22.91 $642,019 - $935,071
40,815 Added 15.79%
299,348 $5.65 Million
Q1 2022

May 16, 2022
BUY
$16.95 - $21.74 $1.28 Million - $1.64 Million
75,469 Added 41.23%
258,533 $5.53 Million
Q4 2021

Feb 14, 2022
SELL
$17.19 - $22.84 $601,856 - $799,674
-35,012 Reduced 16.05%
183,064 $3.73 Million
Q3 2021

Nov 10, 2021
BUY
$22.29 - $28.7 $4.86 Million - $6.26 Million
218,076 New
218,076 $4.86 Million

Others Institutions Holding AORT

# of Institutions
188
Shares Held
38.7M
Call Options Held
19.5K
Put Options Held
2.5K
View Full List

About ARTIVION, INC.

AORT Quotes by TradingView
  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.19B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email